Targeted therapy is a new cancer treatment approach, involving drugs that particularly target
specific proteins in cancer cells, such as receptor tyrosine kinases (RTKs) which are …

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with 85% of all
lung cancer reported as NSCLC. Moreover, there are no effective treatments in advanced …

Background Through activation of adrenergic receptors, chronic stress can trigger the
secretion of neurotransmitters and hormones that enhance tumor growth, increase …

The study was to compare the effectiveness of different epidermal growth factor receptor—
tyrosine kinase inhibitors (EGFR‐TKIs) in patients with advanced non‐small‐cell lung …

Methods A retrospective cohort study of 88 NSCLC patients with EGFR mutation positive
treated with gefitinib (n= 59), erlotinib (n= 22), and afatinib (n= 7) was performed in national …

Malignant cancer is the top cause of mortality in Taiwan. In particular, the mortality rate of
with lung cancer reached 39.2/100,000 in 2017. Epidermal growth factor receptor tyrosine …

Targeted therapy is a new cancer treatment approach, involving drugs that particularly target
speci c proteins in cancer cells, such as receptor tyrosine kinases (RTKs) which are involved …

Adanya identifikasi Epidermal Growth Factor Receptor (EGFR) sebagai target molekular
mempengaruhi model terapi kanker paru jenis Non-Small Cell Lung Cancer (NSCLC) …

Background Lung cancer is a disease that severely endangers human health. Non-small
cell lung cancer (NSCLC) accounts for approximately 4/5 of lung cancers. Aims To …

Background: The bioavailability of BCS class II drugs used in non-small cell lung cancer
(NSCLC) treatment is limited by low water solubility. Also, current therapies for NSCLC …